首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   10011篇
  免费   873篇
  国内免费   367篇
耳鼻咽喉   29篇
儿科学   395篇
妇产科学   88篇
基础医学   1951篇
口腔科学   43篇
临床医学   839篇
内科学   3012篇
皮肤病学   115篇
神经病学   242篇
特种医学   170篇
外科学   666篇
综合类   1534篇
现状与发展   1篇
一般理论   1篇
预防医学   621篇
眼科学   88篇
药学   695篇
  3篇
中国医学   446篇
肿瘤学   312篇
  2024年   22篇
  2023年   139篇
  2022年   471篇
  2021年   615篇
  2020年   472篇
  2019年   335篇
  2018年   299篇
  2017年   330篇
  2016年   326篇
  2015年   365篇
  2014年   514篇
  2013年   644篇
  2012年   531篇
  2011年   558篇
  2010年   442篇
  2009年   414篇
  2008年   373篇
  2007年   417篇
  2006年   392篇
  2005年   369篇
  2004年   353篇
  2003年   313篇
  2002年   277篇
  2001年   282篇
  2000年   242篇
  1999年   221篇
  1998年   206篇
  1997年   189篇
  1996年   132篇
  1995年   118篇
  1994年   118篇
  1993年   96篇
  1992年   84篇
  1991年   79篇
  1990年   62篇
  1989年   81篇
  1988年   61篇
  1987年   54篇
  1986年   38篇
  1985年   60篇
  1984年   33篇
  1983年   30篇
  1982年   22篇
  1981年   12篇
  1980年   17篇
  1979年   9篇
  1978年   13篇
  1977年   4篇
  1976年   10篇
  1973年   2篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Permissive herpes simplex virus (HSV) infection in tissue culture results in host cell destruction. Latent HSV infection in vivo occurs in neurons of peripheral sensory ganglia (PSG) and it therefore can not take place in neurons in which the virus has completed a lytic replication cycle similar to that present in vitro. Our hypothesis, based on experimental data and observations in humans, suggests that establishment of latent infection and reactivation of HSV-1 does not involve neuronal cell loss. Latency is established in neurons in which the virus does not replicate and is determined, in part, by the tissue levels of a herpes transactivating protein (Vmw65) that is a component of the viral tegument. We also suggest that reactivation of latent infection does not involve destruction of neurons and is due to replication of virus at the peripheral mucocutaneous tissues to where virus or viral DNA have been transported from the nervous tissue. Alternatively, reactivation is initiated in the PSG using a replication cycle which does not involve irreversible damage to neurons. This model explains the lack of damage to neurons which continue to serve as permanent reservoirs of latent virus for the entire life of the host.  相似文献   
3.

Objectives

For individuals not on antiretroviral therapy, the risk of heterosexual transmission of HIV appears negligible when blood plasma (BP) viral loads are <1500 HIV‐1 RNA copies/mL. It is not clear whether this observation can be extrapolated to individuals on highly active antiretroviral therapy (HAART). Because of differential tissue penetration, antiretroviral drug concentrations may be sufficient to maintain an undetectable viral load in the BP yet not achieve adequate levels to suppress HIV in the genital tract. Therefore, we wanted to correlate HIV viral loads and drug concentrations in semen plasma (SP) and BP.

Methods

Thirty‐three men were included. All were on combination antiretroviral therapy with an undetectable BP viral load for at least 1 year. Blood and semen samples were collected within 2 h of each other and tested for HIV RNA by the NucliSens QT (bioMerieux, St Laurent, QC, Canada) method; drug concentrations were determined by liquid chromatography tandem mass spectrometry.

Results

Two of the 33 patients (6.1%) with BP viral loads below detection had time‐matched HIV viral loads in SP ≥700 copies/mL. Both patients were on efavirenz, the SP concentrations of which were ≤10% of the levels in BP and well below the minimal therapeutic drug monitoring target concentration required to suppress HIV.

Conclusions

Because, at least in part, of poor drug penetration into the genital tract, an undetectable HIV viral load in the BP does not guarantee an undetectable viral load in semen. In view of this, caution should be taken in concluding that patients on HAART with suppressed viraemia are sexually non‐infectious.  相似文献   
4.
Intravenous ganciclovir is the standard treatment for cytomegalovirus disease in solid organ transplant recipients. Oral valganciclovir is a more convenient alternative. In a randomized, international trial, recipients with cytomegalovirus disease were treated with either 900 mg oral valganciclovir or 5 mg/kg i.v. ganciclovir twice daily for 21 days, followed by 900 mg daily valganciclovir for 28 days. A total of 321 patients were evaluated (valganciclovir [n = 164]; i.v. ganciclovir [n = 157]). The success rate of viremia eradication at Day 21 was 45.1% for valganciclovir and 48.4% for ganciclovir (95% CI -14.0% to +8.0%), and at Day 49; 67.1% and 70.1%, respectively (p = NS). Treatment success, as assessed by investigators, was 77.4% versus 80.3% at Day 21 and 85.4% versus 84.1% at Day 49 (p = NS). Baseline viral loads were not different between groups and decreased exponentially with similar half-lives and median time to eradication (21 vs. 19 days, p = 0.076). Side-effects and discontinuations of assigned treatment (18 of 321 patients) were comparable. Oral valganciclovir shows comparable safety and is not inferior to i.v. ganciclovir for treatment of cytomegalovirus disease in organ transplant recipients and provides a simpler treatment strategy, but care should be taken in extrapolating to organ transplant recipients not properly represented in the present study.  相似文献   
5.
心先安佐治小儿病毒性心肌炎临床疗效分析   总被引:1,自引:0,他引:1  
侯同秀  王自然 《中国民康医学》2004,16(6):333-333,339
目的:分析心先安佐治小儿病毒性心肌炎的临床疗效。方法:136例病毒性心肌炎患儿随机分为治疗组及对照组,在相同的 基础治疗条件下,治疗组应用心先安2~5mg kg,加液静滴,每天2次。结果:心先安组;痊愈51例(75%),好转12例(17.65%),无效5例(7. 35%),总有效92.65%。对照组痊愈41例(60.29%),好转14例(20.59%),无效13例(19.12%),总有效80.88%。两组相比、差异有显著性 (x2=4.09,P<0.005)。结论:心先安治疗小儿病毒性心肌炎疗效确切,且安全、可靠。  相似文献   
6.
Acute viral myocarditis A death associated with anaesthesia   总被引:1,自引:0,他引:1  
The death of a 35-year-old woman in the immediate postoperative period as a result of undiagnosed acute viral myocarditis is described. The presentation, diagnosis and course of the disease is discussed. It is recommended that wider use to be made of routine electrocardiographs as a screening test.  相似文献   
7.
小儿病毒性心肌炎181例,其中暴发性及心源性休克型8例。其主要特点是:心脏增大(43.4%),心律失常(93.9%),其中早搏最多见(59.9%);传导阻滞(15.5%)。作者认为应强调对Ⅱ°-Ⅱ型以上传导阻滞病情严重应给激素及临时起搏器抢救治疗;心电轴异常(35.7%),亦是心肌炎的重要心电图改变之一。  相似文献   
8.
经逆转录病毒载体将人GM-CSF基因导入人膀胱癌细胞株BIU-87细胞中,建立了转基因细胞株BIU/GM。经流式细胞仪行细胞DNA周期分析表明GM-CSF基因的导人及表达对BIU-87细胞的增长无影响。免疫荧光测定发现转GM-CSF基因及表达不能促进BIU-87细胞表面HLA-ABC、DR、DQ抗原的表达。转基因瘤细胞株经6000rad X射线照射灭活后,丧失增殖能力,逐步死亡,但能维持一定水平的GM-CSF分泌活性达两周以上。从而为制备灭活的转基因瘤苗提供了初步经验。  相似文献   
9.
1976~1991年我院收治慢性重症病毒性肝炎并发曲霉菌感染15例,感染于住院后3~112天,<30天9例。以血性痰液、胸水、腹水、脑脊液为特点。多数周围血象白细胞不增高,中性粒细胞增高,IgG增高,曲霉菌( );感染后2~10天均死亡。感染前咽部检出白色念珠菌6例,滥用抗生素者占80%。  相似文献   
10.
本文对28例小儿病毒性心肌炎患者进行了T细胞检测,发现患儿外周血T细胞亚群有明显改变。提示:小儿病毒性心肌炎患者均有不同程度的一过性细胞免疫功能低下。而体液免疫功能正常,我们在临床给与一般治疗的同时,佐以胸腺因子治疗,明显改善症状,取得良好疗效。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号